How current assay approval policies are leading to unintended imprecision medicine.

Salgado, Roberto; Bellizzi, Andrew M; Rimm, David; Bartlett, John M S; Nielsen, Torsten; Holger, Moch; Laenkholm, Anne-Vibeke; Quinn, Cecily; Cserni, Gábor; Cunha, Isabela W; Alvarado-Cabrero, Isabel; Cree, Ian

Salgado, Roberto; Bellizzi, Andrew M; Rimm, David; Bartlett, John M S; Nielsen, Torsten; Holger, Moch; Laenkholm, Anne-Vibeke; Quinn, Cecily; Cserni, Gábor; Cunha, Isabela W; Alvarado-Cabrero, Isabel; Cree, Ian.

Afiliação

Salgado R; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium. Electronic address: roberto@salgado.be.
Bellizzi AM; Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Rimm D; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Bartlett JMS; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Nielsen T; Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.
Holger M; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Quinn C; Department of Pathology, St Vincent's University Hospital, Dublin, Ireland.
Cserni G; Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary; Department of Pathology, University of Szeged, Szeged, Hungary.
Cunha IW; Institute of Anatomical Pathology, Rede D'Or São Luiz Hospitals Network, São Paulo, Brazil; D'Or Institute for Research and Education, Rio de Janeiro and São Paulo, Brazil.
Alvarado-Cabrero I; Department of Pathology, Hospital de Oncología, CMN, SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Cree I; International Agency for Research on Cancer, World Health Organization, Lyon, France.

Lancet Oncol ; 21(11): 1399-1401, 2020 11.

Article em En | MEDLINE | ID: mdl-33098760

Assuntos

Ensaios Clínicos como Assunto; Aprovação de Drogas; Imunoterapia; Neoplasias/tratamento farmacológico; Biomarcadores Farmacológicos; Humanos; Seguro Saúde; Neoplasias/epidemiologia; Medicina de Precisão; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Aprovação de Drogas / Imunoterapia / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google